197 related articles for article (PubMed ID: 11532900)
1. Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis.
McDermott DH; Halcox JP; Schenke WH; Waclawiw MA; Merrell MN; Epstein N; Quyyumi AA; Murphy PM
Circ Res; 2001 Aug; 89(5):401-7. PubMed ID: 11532900
[TBL] [Abstract][Full Text] [Related]
2. Opposite effects of CX3CR1 receptor polymorphisms V249I and T280M on the development of acute coronary syndrome. A possible implication of fractalkine in inflammatory activation.
Niessner A; Marculescu R; Haschemi A; Endler G; Zorn G; Weyand CM; Maurer G; Mannhalter C; Wojta J; Wagner O; Huber K
Thromb Haemost; 2005 May; 93(5):949-54. PubMed ID: 15886814
[TBL] [Abstract][Full Text] [Related]
3. Association of V249I and T280M polymorphisms in the chemokine receptor CX3CR1 gene with early onset of coronary artery disease among North Indians.
Singh N; Rai H; Sinha N; Kumar S; Pandey CM; Agrawal S
Genet Test Mol Biomarkers; 2012 Jul; 16(7):756-60. PubMed ID: 22731642
[TBL] [Abstract][Full Text] [Related]
4. Association of polymorphisms in the chemokine receptor CX3CR1 gene with coronary artery disease.
Matzhold EM; Trummer O; Grünbacher G; Zulus B; Boehm BO; März W; Renner W
Cytokine; 2009 Sep; 47(3):224-7. PubMed ID: 19628406
[TBL] [Abstract][Full Text] [Related]
5. Role of the fractalkine receptor CX3CR1 polymorphisms V249I and T280M as risk factors for early-onset coronary artery disease in patients with no classic risk factors.
Nassar BA; Nanji AA; Ransom TP; Rockwood K; Kirkland SA; Macpherson K; Connelly PW; Johnstone DE; O'Neill BJ; Bata IR; Andreou P; Title LM
Scand J Clin Lab Invest; 2008; 68(4):286-91. PubMed ID: 18609106
[TBL] [Abstract][Full Text] [Related]
6. Cytokine receptor CX3CR-1 and fractalkine: new factors in the atherosclerosis drama?
Alexander RW
Circ Res; 2001 Aug; 89(5):376-7. PubMed ID: 11532896
[No Abstract] [Full Text] [Related]
7. The V249I polymorphism of the CX3CR1 gene is associated with fibrostenotic disease behavior in patients with Crohn's disease.
Sabate JM; Ameziane N; Lamoril J; Jouet P; Farmachidi JP; Soulé JC; Harnois F; Sobhani I; Jian R; Deybach JC; de Prost D; Coffin B
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):748-55. PubMed ID: 18617779
[TBL] [Abstract][Full Text] [Related]
8. Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease.
Moatti D; Faure S; Fumeron F; Amara Mel-W; Seknadji P; McDermott DH; Debré P; Aumont MC; Murphy PM; de Prost D; Combadière C
Blood; 2001 Apr; 97(7):1925-8. PubMed ID: 11264153
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of coronary vascular endothelial dysfunction.
Halcox JP; Schenke WH; Zalos G; Mincemoyer R; Prasad A; Waclawiw MA; Nour KR; Quyyumi AA
Circulation; 2002 Aug; 106(6):653-8. PubMed ID: 12163423
[TBL] [Abstract][Full Text] [Related]
10. Chemokine CX3CL1 and its receptor CX3CR1 are associated with human atherosclerotic lesion volnerability.
Zhang X; Feng X; Cai W; Liu T; Liang Z; Sun Y; Yan C; Han Y
Thromb Res; 2015 Jun; 135(6):1147-53. PubMed ID: 25845619
[TBL] [Abstract][Full Text] [Related]
11. Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery disease.
Apostolakis S; Baritaki S; Kochiadakis GE; Igoumenidis NE; Panutsopulos D; Spandidos DA
Thromb Res; 2007; 119(1):63-71. PubMed ID: 16480760
[TBL] [Abstract][Full Text] [Related]
12. Internal carotid artery occlusive disease and polymorphisms of fractalkine receptor CX3CR1: a genetic risk factor.
Ghilardi G; Biondi ML; Turri O; Guagnellini E; Scorza R
Stroke; 2004 Jun; 35(6):1276-9. PubMed ID: 15118174
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype.
Brand S; Hofbauer K; Dambacher J; Schnitzler F; Staudinger T; Pfennig S; Seiderer J; Tillack C; Konrad A; Göke B; Ochsenkühn T; Lohse P
Am J Gastroenterol; 2006 Jan; 101(1):99-106. PubMed ID: 16405540
[TBL] [Abstract][Full Text] [Related]
14. Lack of association between the functional CX3CR1 polymorphism V249I and hepatocellular carcinoma.
Mühlbauer M; Ringel S; Hartmann A; Lallinger G; Weiss TS; Gäbele E; Wünsch PH; Schölmerich J; Hellerbrand C
Oncol Rep; 2005 May; 13(5):957-63. PubMed ID: 15809764
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of fractalkine receptor CX3CR1 gene in patients with symptomatic and asymptomatic carotid artery stenosis.
Kimouli M; Miyakis S; Georgakopoulos P; Neofytou E; Achimastos AD; Spandidos DA
J Atheroscler Thromb; 2009 Oct; 16(5):604-10. PubMed ID: 19755791
[TBL] [Abstract][Full Text] [Related]
16. Common CX3CR1 alleles are associated with a reduced risk of headaches.
Combadière C; Godin O; Vidal C; Cangialosi A; Proust C; Tzourio C
Headache; 2008 Jul; 48(7):1061-6. PubMed ID: 18194290
[TBL] [Abstract][Full Text] [Related]
17. Relationship of the C242T p22phox gene polymorphism to angiographic coronary artery disease and endothelial function.
Li A; Prasad A; Mincemoyer R; Satorius C; Epstein N; Finkel T; Quyyumi AA
Am J Med Genet; 1999 Sep; 86(1):57-61. PubMed ID: 10440830
[TBL] [Abstract][Full Text] [Related]
18. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart.
Quyyumi AA; Dakak N; Andrews NP; Gilligan DM; Panza JA; Cannon RO
Circulation; 1995 Aug; 92(3):320-6. PubMed ID: 7634444
[TBL] [Abstract][Full Text] [Related]
19. Two polymorphisms in the Fractalkine receptor CX3CR1 gene influence the development of atherosclerosis: a meta-analysis.
Wu J; Yin RX; Lin QZ; Guo T; Shi GY; Sun JQ; Shen SW; Li Q
Dis Markers; 2014; 2014():913678. PubMed ID: 25221380
[TBL] [Abstract][Full Text] [Related]
20. Associations of fractalkine receptor (CX3CR1) and CCR5 gene variants with hypertension, diabetes and atherosclerosis in chronic renal failure patients undergoing hemodialysis.
Bagci B; Bagci G; Huzmeli C; Sezgin I; Ozdemir O
Int Urol Nephrol; 2016 Jul; 48(7):1163-70. PubMed ID: 27118566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
